Symbolbild · KI-generiert
Rubicon Organics Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Rubicon Organics is the Canadian leader in certified organic and premium cannabis. With a vertically integrated model and strong national distribution, the company is scaling a house of trusted, high-performing brands including Simply Bare¿ Organics, 1964 Supply Co.¿, Wildflower¿, and Homestead Cannabis Supply¿. The Company operates two complementary cultivation facilities in British Columbia: the flagship 125,000 square foot Pacifica hybrid greenhouse in Delta and the 47,500 square foot Cascadia indoor facility in Hope. Cascadia is now fully planted and operational, contributing to Rubicon's total current annual production capacity of approximately 15,500 kilograms of premium cannabis. With proprietary genetics, award-winning products, and certifications supporting access to regulated international medical cannabis markets, Rubicon is positioned at the forefront of the premium cannabis segment.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Rubicon Organics Inc. | ROMJ | TSXV | 23 Mio. USD |
| Illumisoft Lighting Corp. | UVC | TSXV | 23 Mio. USD |
| MediPharm Labs Corp. | LABS | TSX | 23 Mio. USD |
| Resverlogix Corp. | RVX | TSX | 23 Mio. USD |
| Medicenna Therapeutics Corp. | MDNA | TSX | 24 Mio. USD |
| Diagnos Inc. | ADK | TSXV | 24 Mio. USD |
| Voyageur Pharmaceuticals Ltd. | VM | TSXV | 21 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.